🇪🇺 Beromun in European Union

EMA authorised Beromun on 13 April 1999

Marketing authorisation

EMA — authorised 13 April 1999

  • Marketing authorisation holder: Boehringer Ingelheim International GmbH
  • Status: approved

Beromun in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Beromun approved in European Union?

Yes. EMA authorised it on 13 April 1999.

Who is the marketing authorisation holder for Beromun in European Union?

Boehringer Ingelheim International GmbH holds the EU marketing authorisation.